# High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML

> **NCT03080922** · PHASE1,PHASE2 · UNKNOWN · sponsor: **The Affiliated Hospital of the Chinese Academy of Military Medical Sciences** · enrollment: 10 (estimated)

## Conditions studied

- Leukemia, Myeloid

## Interventions

- **BIOLOGICAL:** hematopoietic stem cell

## Key facts

- **NCT ID:** NCT03080922
- **Lead sponsor:** The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2018-03
- **Final completion:** 2019-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03080922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03080922, "High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03080922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*